The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2016; 44(2): 26-32

The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy

Mesut Demir
Çukurova Üniversitesi Tıp Fakültesi, Kardiyoloji Anabilim Dalı, Adana

Atrial fibrillation (AF) is a strong, independent risk factor for stroke. Until recent years, only aspirin and warfarin were approved treatment options for prophylaxis of stroke in patients with AF. Although warfarin has shown significant superiority compared to placebo and aspirin in preventing stroke, challenges in its usage necessitated new treatment searches. New oral anticoagulants affect different factors in coagulation cascade and studies with this drugs was shown to be effective and safe. In this review, we evaluated the efficacy and safety of apixaban in patients that can not use warfarin therapy.

Keywords: Atrial fibrillation, prophylaxis, warfarin.

How to cite this article
Mesut Demir. The use of new oral anticoagulants in atrial fibrillation patients unsuitable for warfarin therapy. Turk Kardiyol Dern Ars. 2016; 44(2): 26-32

Corresponding Author: Mesut Demir, Türkiye
© Copyright 2020 Archives of the Turkish Society of Cardiology
LookUs & Online Makale